IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE

N/A

Manufactured by American Health Packaging

3,750 FDA adverse event reports analyzed

Last updated: 2026-04-15

About IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE

IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by American Health Packaging. The most commonly reported adverse reactions for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE include DYSPNOEA, DRUG INEFFECTIVE, PNEUMONIA, COUGH, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE.

Top Adverse Reactions

DYSPNOEA254 reports
DRUG INEFFECTIVE163 reports
PNEUMONIA109 reports
COUGH99 reports
FATIGUE99 reports
NAUSEA86 reports
HEADACHE76 reports
DEATH75 reports
DIZZINESS67 reports
DIARRHOEA66 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE65 reports
OFF LABEL USE65 reports
PAIN63 reports
ASTHENIA62 reports
MALAISE60 reports
ASTHMA55 reports
DYSGEUSIA55 reports
FALL55 reports
TREMOR50 reports
CHEST PAIN48 reports
PRODUCT QUALITY ISSUE47 reports
URINARY TRACT INFECTION44 reports
WEIGHT DECREASED44 reports
ARTHRALGIA42 reports
PAIN IN EXTREMITY42 reports
CONSTIPATION40 reports
PERIPHERAL SWELLING40 reports
PRODUCT USE IN UNAPPROVED INDICATION40 reports
PRODUCT DOSE OMISSION ISSUE38 reports
VOMITING38 reports
ANXIETY36 reports
OROPHARYNGEAL PAIN35 reports
PRODUCTIVE COUGH35 reports
RASH35 reports
BRONCHITIS34 reports
CONDITION AGGRAVATED34 reports
BACK PAIN33 reports
MUSCLE SPASMS33 reports
PYREXIA33 reports
DYSPHONIA32 reports
PRODUCT TASTE ABNORMAL32 reports
OXYGEN SATURATION DECREASED31 reports
VISION BLURRED31 reports
WEIGHT INCREASED31 reports
GAIT DISTURBANCE30 reports
HYPERTENSION30 reports
OEDEMA PERIPHERAL30 reports
PRURITUS30 reports
WHEEZING30 reports
NASOPHARYNGITIS29 reports
SINUSITIS29 reports
DECREASED APPETITE27 reports
HYPOXIA27 reports
FEELING ABNORMAL26 reports
HYPOTENSION26 reports
NERVOUSNESS26 reports
HYPERSENSITIVITY25 reports
DRY MOUTH24 reports
CHEST DISCOMFORT23 reports
CONFUSIONAL STATE23 reports
HEART RATE INCREASED23 reports
INSOMNIA23 reports
LIQUID PRODUCT PHYSICAL ISSUE23 reports
EXPIRED PRODUCT ADMINISTERED22 reports
INFLUENZA22 reports
RESPIRATORY FAILURE22 reports
BLOOD PRESSURE INCREASED21 reports
DYSPHAGIA21 reports
DYSPNOEA EXERTIONAL21 reports
PALPITATIONS21 reports
PRODUCT PACKAGING QUANTITY ISSUE21 reports
PRODUCT USE ISSUE21 reports
CHILLS20 reports
NASAL CONGESTION20 reports
RESPIRATORY TRACT INFECTION20 reports
ABDOMINAL PAIN19 reports
ABDOMINAL PAIN UPPER19 reports
ANAEMIA19 reports
ATRIAL FIBRILLATION19 reports
CARDIAC FAILURE CONGESTIVE19 reports
DRUG INTERACTION19 reports
ILLNESS19 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION19 reports
INFECTION19 reports
INTENTIONAL PRODUCT MISUSE19 reports
SEPSIS19 reports
DYSPEPSIA18 reports
HYPOAESTHESIA18 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS18 reports
COVID 1917 reports
DEHYDRATION17 reports
RHINORRHOEA17 reports
THROAT IRRITATION17 reports
UPPER RESPIRATORY TRACT INFECTION17 reports
CONTUSION16 reports
DEPRESSION16 reports
DRUG DOSE OMISSION16 reports
EPISTAXIS16 reports
ABDOMINAL DISCOMFORT15 reports
ACUTE RESPIRATORY FAILURE15 reports

Report Outcomes

Out of 1,563 classified reports for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE:

Serious 49.5%Non-Serious 50.5%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female727 (62.8%)
Male431 (37.2%)

Reports by Age

Age 7631 reports
Age 6330 reports
Age 7230 reports
Age 6928 reports
Age 7828 reports
Age 6827 reports
Age 7527 reports
Age 7025 reports
Age 7425 reports
Age 7725 reports
Age 6424 reports
Age 7324 reports
Age 7122 reports
Age 8620 reports
Age 5719 reports
Age 6018 reports
Age 6116 reports
Age 8216 reports
Age 5215 reports
Age 5315 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE?

This profile reflects 3,750 FDA FAERS reports that mention IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE?

Frequently reported terms in FAERS include DYSPNOEA, DRUG INEFFECTIVE, PNEUMONIA, COUGH, FATIGUE, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE?

Labeling and FAERS entries often list American Health Packaging in connection with IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.